References

• 1992The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.33,714 cited
• 1960A RATING SCALE FOR DEPRESSION32,812 cited
• 1992The MOS 36-ltem Short-Form Health Survey (SF-36)30,026 cited
• 1998The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-1019,139 cited
• 1998Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment7,917 cited
• 2011Preliminary Psychometric Properties of the Acceptance and Action Questionnaire–II: A Revised Measure of Psychological Inflexibility and Experiential Avoidance3,948 cited
• 1994The temperament and character inventory (TCI) : a guide to its development and use2,319 cited
• 2017Psilocybin with psychological support for treatment-resistant depression: six-month follow-up969 cited
• 1995[The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results].950 cited
• 2008Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later901 cited
• 2018Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial851 cited
• 2017Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms587 cited
• 2015Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report